Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
about
Targeting MYC in cancer therapy: RNA processing offers new opportunities.Pre-clinical drug screen reveals topotecan, actinomycin D and volasertib as potential new therapeutic candidates for ETMR brain tumor patients.Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.
P2860
Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Mechanism of action and therap ...... verexpressing medulloblastoma.
@ast
Mechanism of action and therap ...... verexpressing medulloblastoma.
@en
type
label
Mechanism of action and therap ...... verexpressing medulloblastoma.
@ast
Mechanism of action and therap ...... verexpressing medulloblastoma.
@en
prefLabel
Mechanism of action and therap ...... verexpressing medulloblastoma.
@ast
Mechanism of action and therap ...... verexpressing medulloblastoma.
@en
P2093
P2860
P356
P1433
P1476
Mechanism of action and therap ...... overexpressing medulloblastoma
@en
P2093
Annie Huang
Brian Golbourn
Christian A Smith
Daniel Picard
Danielle MacKenzie
Denis Raynaud
James T Rutka
Matthew Bebenek
Melissa Bryant
Michael D Taylor
P2860
P304
P356
10.18632/ONCOTARGET.3245
P407
P577
2015-02-01T00:00:00Z